BSECompany Update2 Nov 2026 · 2 Nov 2026, 05:03 pm

Non - Applicability of Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI (LODR) Regualtions, 2015.

Symbiox Investment & Trading Company Ltd · 539278

✦ AI Summary

Symbiox Investment & Trading Company Ltd has confirmed that it did not raise any funds through public issue, rights issue, or preferential issue during the quarter ended September 30, 2026, and therefore, the statement of deviation or variation in utilization of funds under Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Symbiox Investment & Trading Company Ltd - 539278 - Non - Applicability Of Statement Of Deviation Or Variation In Utilisation Of Funds Under Regulation 32 Of SEBI (LODR) Regulations, 2015.

Attachments (1)

📄

0163319f-62c0-4824-bc92-772cde2f7756.pdf

pdf

Download →
View document text
Syymmbiboxi ox Investmen&t Tradii ng Co. Ltd. 2o21, R abind ora LSarani, 3 trdFl Contact: 98302 74227 CIN : L65993WB1979PLC032012 Website : www.symbioxinvestment.com E-mail : symbioxinvestment100@gmail.com Date: 2" November, 2026 To, To, Compliance Department The Calcutta Stock Exchange Limited Metropolitan Stock Exchange of India Limited 7 Lyons Range, Vibgyor Towers, 4th floor, Plot No C 62, G - Block, Kolkata —700 001 Opp. Trident Hotel, Bandra Kurla Complex, Bandra (E), Mumbai — 400 098 The Bombay Stock Exchange Limited Corporate Relationship Dept, Phiroze Jegjeebhoy Towers Dalal Street Mumbai- 400001 Sub: Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ref. Script Code:- BSE-539278; MSEI- SYMBIOX: CSE- 029461 Dear Sir/ Madam, Pursuant to the Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby confirms, that Company has not raised any funds through Public Issue, Rights Issue, Preferential Issue, QIP etc. during the quarter ended 30™ September, 2026. Hence. the statement of Deviation or variation in Public Issue, Rights Issue, Preferential issue, etc under Regulation 32 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 for the quarter ended 30" September, 2026 is not applicable to the Company. This is for your kind perusal and please acknowledge the same. Thanking You. Yours faithfully For, Symbiox Investment & Lrading Co. Ltd, Company Secretary & Conipliance Officer Membership No. A25950